These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17545532)

  • 81. The emerging role of computerized tomography in assessing cancer cachexia.
    Prado CM; Birdsell LA; Baracos VE
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):269-75. PubMed ID: 19667996
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service.
    Parsons HA; Baracos VE; Dhillon N; Hong DS; Kurzrock R
    PLoS One; 2012; 7(1):e29330. PubMed ID: 22235285
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Low skeletal muscle is associated with toxicity in patients included in phase I trials.
    Cousin S; Hollebecque A; Koscielny S; Mir O; Varga A; Baracos VE; Soria JC; Antoun S
    Invest New Drugs; 2014 Apr; 32(2):382-7. PubMed ID: 24343673
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cachexia: a new definition.
    Evans WJ; Morley JE; Argilés J; Bales C; Baracos V; Guttridge D; Jatoi A; Kalantar-Zadeh K; Lochs H; Mantovani G; Marks D; Mitch WE; Muscaritoli M; Najand A; Ponikowski P; Rossi Fanelli F; Schambelan M; Schols A; Schuster M; Thomas D; Wolfe R; Anker SD
    Clin Nutr; 2008 Dec; 27(6):793-9. PubMed ID: 18718696
    [TBL] [Abstract][Full Text] [Related]  

  • 85. ESPEN guidelines on nutrition in cancer patients.
    Arends J; Bachmann P; Baracos V; Barthelemy N; Bertz H; Bozzetti F; Fearon K; Hütterer E; Isenring E; Kaasa S; Krznaric Z; Laird B; Larsson M; Laviano A; Mühlebach S; Muscaritoli M; Oldervoll L; Ravasco P; Solheim T; Strasser F; de van der Schueren M; Preiser JC
    Clin Nutr; 2017 Feb; 36(1):11-48. PubMed ID: 27637832
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
    Hilmi M; Jouinot A; Burns R; Pigneur F; Mounier R; Gondin J; Neuzillet C; Goldwasser F
    Pharmacol Ther; 2019 Apr; 196():135-159. PubMed ID: 30521882
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
    Mitsiopoulos N; Baumgartner RN; Heymsfield SB; Lyons W; Gallagher D; Ross R
    J Appl Physiol (1985); 1998 Jul; 85(1):115-22. PubMed ID: 9655763
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
    Shachar SS; Williams GR; Muss HB; Nishijima TF
    Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
    Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
    Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.
    van den Berg MMGA; Kok DE; Posthuma L; Kamps L; Kelfkens CS; Buist N; Geenen M; Haringhuizen A; Heijns JB; van Lieshout RHMA; Los M; Sommeijer DW; Timmer-Bonte JNH; de Kruif ATCM; van Laarhoven HWM; Kampman E; Winkels RM
    Breast Cancer Res Treat; 2019 Jan; 173(2):475-481. PubMed ID: 30353244
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients.
    Wong AL; Seng KY; Ong EM; Wang LZ; Oscar H; Cordero MT; Copones R; Fan L; Tan SH; Goh BC; Lee SC
    Breast Cancer Res Treat; 2014 Feb; 144(1):143-52. PubMed ID: 24481679
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer.
    Shachar SS; Deal AM; Weinberg M; Williams GR; Nyrop KA; Popuri K; Choi SK; Muss HB
    Clin Cancer Res; 2017 Jul; 23(14):3537-3543. PubMed ID: 28143874
    [No Abstract]   [Full Text] [Related]  

  • 93. Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
    Arrieta O; De la Torre-Vallejo M; López-Macías D; Orta D; Turcott J; Macedo-Pérez EO; Sánchez-Lara K; Ramírez-Tirado LA; Baracos VE
    Oncologist; 2015 Aug; 20(8):967-74. PubMed ID: 26173839
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A review of body composition and pharmacokinetics in oncology.
    Hopkins JJ; Sawyer MB
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):947-956. PubMed ID: 28649898
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer.
    Williams GR; Deal AM; Shachar SS; Walko CM; Patel JN; O'Neil B; McLeod HL; Weinberg MS; Choi SK; Muss HB; Sanoff HK
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):413-417. PubMed ID: 29159476
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study.
    Massicotte MH; Borget I; Broutin S; Baracos VE; Leboulleux S; Baudin E; Paci A; Deroussent A; Schlumberger M; Antoun S
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2401-8. PubMed ID: 23543666
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer.
    Sealy MJ; Dechaphunkul T; van der Schans CP; Krijnen WP; Roodenburg JLN; Walker J; Jager-Wittenaar H; Baracos VE
    Clin Nutr; 2020 Feb; 39(2):501-509. PubMed ID: 30846324
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.
    Mazzuca F; Onesti CE; Roberto M; Di Girolamo M; Botticelli A; Begini P; Strigari L; Marchetti P; Muscaritoli M
    Oncotarget; 2018 May; 9(39):25714-25722. PubMed ID: 29876019
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Early breast cancer: why does obesity affect prognosis?
    Heetun A; Cutress RI; Copson ER
    Proc Nutr Soc; 2018 Nov; 77(4):369-381. PubMed ID: 29860965
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer.
    Sjøblom B; Grønberg BH; Benth JŠ; Baracos VE; Fløtten Ø; Hjermstad MJ; Aass N; Jordhøy M
    Lung Cancer; 2015 Oct; 90(1):85-91. PubMed ID: 26198373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.